GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Immune Cells and Secretory Pathways Leading to Human Systemic Autoimmunity

$550,875
Maria Virginia Pascual · Weill Medical Coll Of Cornell Univ · U19 · FY2019 · AI

Data Processing, Analysis and Modeling Unit

$550,875
Dana Pe'er · Sloan-Kettering Inst Can Research · U2C · FY2022 · CA

Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer

$550,839
Michelle S Bradbury · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

Develop Conditionally Armored CAR Macrophage Therapy for Pancreatic Cancer

$550,769
Pingping Hou · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA

Project 3: Phase-2 Trial of Oncolytic Poliovirus (PVSRIPO) combined with CCNU (lomustine) against Recurrent Glioblastoma

$550,752
Darell D Bigner · Duke University · P01 · FY2022 · CA

Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy

$550,644
Jin-Ming Yang · University Of Kentucky · R01 · FY2023 · CA

Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy

$550,643
Jin-Ming Yang · University Of Kentucky · R01 · FY2022 · CA

Image-guided combination therapy: noninvasive assessment of delivery and response

$550,634
Dmitri Artemov · Johns Hopkins University · R01 · FY2014 · CA

Image-guided combination therapy: noninvasive assessment of delivery and response

$550,456
Dmitri Artemov · Johns Hopkins University · R01 · FY2013 · CA

The Role of Proteases and Peptides in Cancer Pain

$550,454
Brian L Schmidt · New York University · R01 · FY2011 · DE

The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma

$550,450
Charles S Cobbs · Swedish Medical Center, First Hill · R01 · FY2016 · CA

Precision lung cancer therapy design through multiplexed adapter measurement

$550,445
Aaron Samuel Meyer · University Of California Los Angeles · U01 · FY2018 · CA

BATF as an inducible regulator of natural killer cell expansion and effector function

$550,375
Barbara Lynne Kee · University Of Chicago · R01 · FY2025 · AI

Next generation oncolytic virotherapy targeting AKT and ERK signaling in glioma

$550,350
Balveen Kaur · Augusta University · R01 · FY2025 · NS

Reprogramming the tumor microenvironment via self-amplified RNA (SafeR) circuits

$550,228
Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2016 · CA

Reprogramming the tumor microenvironment via self-amplified RNA (SafeR) circuits

$550,228
Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2020 · CA

Reprogramming the tumor microenvironment via self-amplified RNA (SafeR) circuits

$550,228
Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2018 · CA

Reprogramming the tumor microenvironment via self-amplified RNA (SafeR) circuits

$550,228
Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2017 · CA

Optimizing singlet oxygen dosimetry for photodynamic therapy (PDT)

$550,210
Timothy C Zhu · University Of Pennsylvania · R01 · FY2022 · EB

Gut Microbiome, Antibiotic Use & Colon Cancer Recurrence

$550,130
Veronika Fedirko · Emory University · R01 · FY2017 · CA

Pathways to Cancer Therapeutics

$550,112
Susan E Waltz · University Of Cincinnati · T32 · FY2020 · CA

Macrophage phenotype polarization in clinical neoplasia

$550,086
Jan Matt Van De Rijn · Stanford University · R01 · FY2018 · CA

Macrophage phenotype polarization in clinical neoplasia

$550,086
Jan Matt Van De Rijn · Stanford University · R01 · FY2021 · CA

Macrophage phenotype polarization in clinical neoplasia

$550,086
Jan Matt Van De Rijn · Stanford University · R01 · FY2020 · CA

A Human Intraepithelial Tumor Microenvironment Assay

$550,042
Barbara Lynn Allen-Hoffmann · Stratatech Corporation · R42 · FY2011 · CA